These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care. Garimella PS, Hart PD, O'Hare A, DeLoach S, Herzog CA, Hirsch AT. Am J Kidney Dis; 2012 Oct; 60(4):641-54. PubMed ID: 22560831 [Abstract] [Full Text] [Related]
5. Endovascular treatment of lower extremity peripheral arterial disease. Klein AJ, Ross CB. Trends Cardiovasc Med; 2016 Aug; 26(6):495-512. PubMed ID: 27345154 [Abstract] [Full Text] [Related]
6. Outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end-stage renal disease. Adedokun SD, Sarwar M, Hwang K, Hans A, Baskaran J, Anantha Narayanan M. J Cardiovasc Surg (Torino); 2023 Dec; 64(6):624-633. PubMed ID: 38078709 [Abstract] [Full Text] [Related]
7. Systematic review and meta-analysis of outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end-stage renal disease. Anantha-Narayanan M, Sheikh AB, Nagpal S, Jelani QU, Smolderen KG, Regan C, Ionescu C, Ochoa Chaar CI, Schneider M, Llanos-Chea F, Mena-Hurtado C. J Vasc Surg; 2021 Jan; 73(1):331-340.e4. PubMed ID: 32889074 [Abstract] [Full Text] [Related]
10. Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease. Di Minno G, Spadarella G, Cafaro G, Petitto M, Lupoli R, Di Minno A, de Gaetano G, Tremoli E. Ann Med; 2014 Nov; 46(7):475-89. PubMed ID: 25045928 [Abstract] [Full Text] [Related]
11. Prevalence and risk factors of peripheral artery disease in a population with chronic kidney disease in Australia: A systematic review and meta-analysis. Ho CLB, Chih HJ, Garimella PS, Matsushita K, Jansen S, Reid CM. Nephrology (Carlton); 2021 Oct; 26(10):798-808. PubMed ID: 34156137 [Abstract] [Full Text] [Related]
12. Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance. Layden J, Michaels J, Bermingham S, Higgins B, Guideline Development Group. BMJ; 2012 Aug 08; 345():e4947. PubMed ID: 22875949 [No Abstract] [Full Text] [Related]
13. Peripheral artery disease, chronic kidney disease, and recurrent admissions for acute decompensated heart failure: The ARIC study. Chunawala ZS, Bhatt DL, Qamar A, Vaduganathan M, Mentz RJ, Matsushita K, Grodin JL, Pandey A, Caughey MC. Atherosclerosis; 2024 Aug 08; 395():118521. PubMed ID: 38968642 [Abstract] [Full Text] [Related]
15. The effect of acute kidney injury after revascularization on the development of chronic kidney disease and mortality in patients with chronic limb ischemia. Arora P, Davari-Farid S, Pourafkari L, Gupta A, Dosluoglu HH, Nader ND. J Vasc Surg; 2015 Mar 08; 61(3):720-7. PubMed ID: 25499712 [Abstract] [Full Text] [Related]
16. Peripheral Arterial Disease and Chronic Kidney Disease. Bosevski M. Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Sep 01; 38(2):29-33. PubMed ID: 28991768 [Abstract] [Full Text] [Related]
17. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study. Subherwal S, Patel MR, Kober L, Peterson ED, Bhatt DL, Gislason GH, Olsen AM, Jones WS, Torp-Pedersen C, Fosbol EL. Eur J Prev Cardiol; 2015 Mar 01; 22(3):317-25. PubMed ID: 24398369 [Abstract] [Full Text] [Related]
18. Unique aspects of peripheral artery disease in patients with chronic kidney disease. Arinze NV, Gregory A, Francis JM, Farber A, Chitalia VC. Vasc Med; 2019 Jun 01; 24(3):251-260. PubMed ID: 30823859 [Abstract] [Full Text] [Related]
19. Comprehensive evaluation and medical management of infrainguinal peripheral artery disease: "when to treat, when not to treat". Kiernan TJ, Hynes BG, Ruggiero NJ, Yan BP, Jaff MR. Tech Vasc Interv Radiol; 2010 Mar 01; 13(1):2-10. PubMed ID: 20123428 [Abstract] [Full Text] [Related]
20. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50). Bonaca MP, Gutierrez JA, Creager MA, Scirica BM, Olin J, Murphy SA, Braunwald E, Morrow DA. Circulation; 2016 Mar 08; 133(10):997-1005. PubMed ID: 26826179 [Abstract] [Full Text] [Related] Page: [Next] [New Search]